Source: International Congress 2018 – COPD: from LABA/ICS to LABA/LAMA/ICS
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Andreas (Göttingen, Germany), U. Bothner (Ingelheim am Rhein, Germany), A. De La Hoz (Ingelheim am Rhein, Germany), I. Kloer (Ingelheim am Rhein, Germany), M. Trampisch (Ingelheim am Rhein, Germany), P. Alter (Marburg, Germany). Late Breaking Abstract - Holter ECG-based arrhythmia and heart rate analysis in patients with COPD receiving a fixed-dose combination of tiotropium/olodaterol versus its monocomponents. 2126

Member's Comments

No comment yet.

Related content which might interest you: Evaluating cardiac safety of tiotropium in patients with COPD: Combined analysis of Holter-ECG data from four trials Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014 Effects of tiotropium bromide and fluticasone propionate/salmeterol on myocardial ischemia in patients (pts) with COPD and stable angina during 24-hour ambulatory Holter ECG monitoring Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Effects of nebivolol and ivabradine on myocardial ischemia in patients (pts) with COPD and stable angina during 24-hour ambulatory Holter ECG monitoring. Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017 Cardiac events among patients with CV comorbidities: Pooled analysis of COPD trials comparing tiotropium with salmeterol Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013 Continuous indacaterol treatment improves autonomic cardiac regulation in COPD patients Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Effects of nebivolol and ivabradine on the left ventricular diastolic function in patients (pts) with COPD and stable angina Source: International Congress 2014 – COPD markers Year: 2014 Myocardial ischemia in patients (pts) with COPD and stable angina during 24-hour ambulatory Holter ECG monitoring Source: International Congress 2015 – COPD: interesting notes Year: 2015 Overall and cardiovascular safety of aclidinium/formoterol fixed-dose combination versus salmeterol/fluticasone in patients with COPD Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015 Safety of tiotropium in patients with cardiac events in the TIOSPIR™ trial Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015 Evaluation of a new cardiac arrhythmias predictor in patients with COPD Source: International Congress 2018 – Cardiovascular morbidities in COPD Year: 2018 QVA149 improves dyspnoea and lung function versus tiotropium in symptomatic patients using LABA/ICS preceding study enrolment: The BLAZE study Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Late Breaking Abstract - Morbidity and mortality of chronic heart failure (CHF) patients with central sleep apnoea (CSA) treated by adaptive servoventilation (ASV): Interim results of FACE cohort study_Update Source: International Congress 2017 – Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea Year: 2017 Late Breaking Abstract - The effectiveness of electrical impedance spirometry in heart insufficiency diagnostics in COPD patients Source: International Congress 2018 – New methods and concepts in exercise testing Year: 2018 Late-breaking abstract: HR-lowering efficacy and respiratory safety of ivabradine in patients with obstructive airway disease Source: Annual Congress 2011 - COPD: integrated care and rehabilitation Year: 2011 Safety of tiotropium in patients with cardiac events in the UPLIFT® trial Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015 Late Breaking Abstract - Characteristics and treatment of patients with comorbid COPD and heart failure Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Assessment of cardiac events via 24-hour electrocardiographic (Holter) monitoring with cilomilast in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 66s Year: 2003 Efficacy and safety of QVA149 compared with salmeterol/fluticasone combination (SFC) in Chinese patients with moderate-to-severe COPD: A subgroup analysis from the LANTERN study Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015 Carvedilol, bisoprolol, and metoprolol use in patients with coexistent heart failure and chronic obstructive pulmonary disease: A nationwide population-based study Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Once-daily QVA149 improves dyspnoea, lung function and reduces rescue medication use in symptomatic patients with COPD using LAMA as prior medication: The BLAZE study Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014